| Gen-Probe announced that the US Food and Drug Administration has cleared for marketing Prodesse's ProParaflu+ assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections. Prodesse is a wholly-owned subsidiary of Gen-Probe, a global leader in molecular diagnostics. :theflyonthewall.com |
